These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 35261320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early Experience with Crotalidae Immune F(ab')2 Antivenom to Treat Arizona Rattlesnake Envenomations.
    Ruha AM, Padilla-Jones A, Canning J, Spyres MB, Curry SC.
    J Med Toxicol; 2022 Jan; 18(1):38-42. PubMed ID: 34665424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
    Wilson BZ, Bahadir A, Andrews M, Karpen J, Winkler G, Smelski G, Dudley S, Walter FG, Shirazi FM.
    Toxicon; 2022 Apr 15; 209():10-17. PubMed ID: 35085602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom.
    Maciulewicz TS, Axon DR, Shirazi FM.
    Clin Toxicol (Phila); 2024 Nov 15; 62(11):749-753. PubMed ID: 39318272
    [Abstract] [Full Text] [Related]

  • 7. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
    Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD.
    Ann Emerg Med; 2002 Dec 15; 40(6):619-24. PubMed ID: 12447339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA, Mascarenas DN, Fullerton L, Warrick BJ, Smolinske SC.
    Toxicon; 2020 Sep 15; 184():55-56. PubMed ID: 32505639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of two Antivenoms in the treatment of eastern copperhead (Agkistrodon contortrix) envenomations in Southeast Texas.
    Greene S, Teshon A.
    J Am Coll Emerg Physicians Open; 2024 Oct 15; 5(5):e13310. PubMed ID: 39364389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
    Keating GM.
    BioDrugs; 2011 Apr 01; 25(2):69-76. PubMed ID: 21443271
    [Abstract] [Full Text] [Related]

  • 17. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH, Tanen DA, Tong TC, Betten DP, Carstairs SD, Williams SR, Cantrell FL, Clark RF.
    Ann Emerg Med; 2005 Jun 01; 45(6):595-602. PubMed ID: 15940091
    [Abstract] [Full Text] [Related]

  • 18. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
    Dudley S, Smelski G, Massey DJ, Maciulewicz T, Cardwell MD, Shirazi FM.
    Toxicon; 2022 Jun 01; 212():49-54. PubMed ID: 35413335
    [Abstract] [Full Text] [Related]

  • 19. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
    Kleinschmidt K, Ruha AM, Campleman S, Brent J, Wax P, ToxIC North American Snakebite Registry Group.
    Clin Toxicol (Phila); 2018 Nov 01; 56(11):1115-1120. PubMed ID: 29688079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.